ArticleMolecules (Basel, Switzerland)2012

Pristimerin, a triterpenoid, inhibits tumor angiogenesis by targeting VEGFR2 activation.

Xianmin Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.